Stockholders' Equity - Market Capitalization (Details) - USD ($)	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative
Gains on revaluation of derivative liabilities	$ 2,590,000	$ 460,000
Maximum \| Metuchen
Collaborative Arrangement and Arrangement Other than Collaborative
Milestone earnout payments (in shares)	400,000
Market Capitalization/Gross Proceeds Earnout Payments \| Metuchen
Collaborative Arrangement and Arrangement Other than Collaborative
Fair value of the derivative liability		0.0
Gains on revaluation of derivative liabilities		$ 500,000
Market Capitalization/Gross Proceeds Earnout Payments \| Maximum \| Metuchen
Collaborative Arrangement and Arrangement Other than Collaborative
Milestone earnout payments (in shares)	1,023,209

Represents the number of shares to be issued as part of milestone earnout payments.

No definition available.

Name:	ptpi_SharesToBeIssuedAsPartOfMilestoneEarnoutPayments
Namespace Prefix:	ptpi_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483444/210-20-55-22

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483466/210-20-50-3

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483444/210-20-55-7

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (a),(c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (c)(2)
-SubTopic 20
-Topic 860
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D

+ Details

Name:	us-gaap_DerivativeFairValueOfDerivativeLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A

+ Details

Name:	us-gaap_DerivativeGainLossOnDerivativeNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ptpi_MetuchenPharmaceuticalsLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ptpi_EarnoutPaymentsMethodAxis=ptpi_MarketCapitalizationOrGrossProceedsEarnoutPaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: